Large-scale testing (Phase 3)Study completedNCT00295620What this trial is testingSecondary Adjuvant Long Term Study With ArimidexWho this might be right forBreast Cancer AstraZeneca 3,484
Early research (Phase 1)WithdrawnNCT04498520What this trial is testingAbexinostat, Palbociclib, and Fulvestrant for the Treatment of Breast or Gynecologic CancerWho this might be right forAnatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Anatomic Stage IIIB Breast Cancer AJCC v8+32 more Pamela Munster
Post-approval studies (Phase 4)UnknownNCT03270007What this trial is testingResearch of Intensive Treatment in Hormone Receptor<10% and Human Epidermal Growth Factor Receptor-2 Negative Breast Cancer Patients With Positive Lymph Node Residual Disease After Neoadjuvant ChemotherapyWho this might be right forPrimary Breast Cancer Tao OUYANG 304
Large-scale testing (Phase 3)Study completedNCT01864746What this trial is testingPalbociclib in Addition to Standard Endocrine Treatment in Hormone Receptor Positive Her2 Normal Patients With Residual Disease After Neoadjuvant Chemotherapy and SurgeryWho this might be right forBreast CancerHormonreceptor PositiveHer2-normal+2 more GBG Forschungs GmbH 1,250
Large-scale testing (Phase 3)Study completedNCT00256698What this trial is testingAnastrozole Monotherapy Versus Maximal Oestrogen Blockade With Anastrozole and Fulvestrant Combination TherapyWho this might be right forBreast Cancer AstraZeneca 514
Large-scale testing (Phase 3)Study completedNCT00535418What this trial is testingOptimal Duration of Pre-operative Treatment With Letrozole and to Correlate Clinical Efficacy With Appropriate Surrogate MarkersWho this might be right forBreast Cancer Novartis Pharmaceuticals 35
Testing effectiveness (Phase 2)Study completedNCT01972984What this trial is testingFeasibility Study of Presurgical Hormone Therapy (Anastrozole) in Breast Cancer PatientsWho this might be right forBreast Cancer Ottawa Hospital Research Institute 20
Not applicableEnded earlyNCT00555867What this trial is testingPatient's Anastrozole Compliance to Therapy ProgrammeWho this might be right forBreast Cancer AstraZeneca 4,923
Not applicableStudy completedNCT00638391What this trial is testingAx-003/Arimidex (Anastrozole) in the Adjuvant Therapy of Early Breast CancerWho this might be right forBreast Cancer AstraZeneca 1,600
Testing effectiveness (Phase 2)Looking for participantsNCT05985655What this trial is testingStudy to Assess GTAEXS617 in Participants With Advanced Solid TumorsWho this might be right forHead and Neck Squamous Cell Carcinoma (HNSCC)Pancreatic AdenocarcinomaNon-small Cell Lung Cancer (NSCLC)+3 more Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc. 230
Testing effectiveness (Phase 2)Active Not RecruitingNCT04298086What this trial is testingThe Body's Response to Exercise and a Plant-Based Diet in Overweight Postmenopausal Women With Breast CancerWho this might be right forBreast CancerPrimary Hormone Receptor Positive Breast Cancer Memorial Sloan Kettering Cancer Center 43
Not applicableEnded earlyNCT02149173What this trial is testingF-18 FES PET/CT in Measuring Hormone Expression in Patients With Primary, Recurrent, or Metastatic Breast Cancer Undergoing Endocrine-Targeted TherapyWho this might be right forEstrogen Receptor PositiveRecurrent Breast CarcinomaStage IV Breast Cancer AJCC v6 and v7 University of Washington 29
Testing effectiveness (Phase 2)Study completedNCT02760030What this trial is testingEndocrine Therapy Fulvestrant & Palbociclib or Aromatase Inhibitor Therapy in Treating Older Patients With Hormone Responsive Breast Cancer That Cannot Be Removed by SurgeryWho this might be right forEstrogen Receptor and/or Progesterone Receptor PositiveHER2/Neu NegativeStage IA Breast Cancer+6 more Ohio State University Comprehensive Cancer Center 14
Large-scale testing (Phase 3)Study completedNCT02422615What this trial is testingStudy of Efficacy and Safety of LEE011 in Men and Postmenopausal Women With Advanced Breast Cancer.Who this might be right forAdvanced Breast Cancer Novartis Pharmaceuticals 726
Testing effectiveness (Phase 2)Ended earlyNCT00206414What this trial is testingArimidex/Faslodex/Iressa Study: A Trial Using Arimidex, Faslodex and Iressa in Women With Breast CancerWho this might be right forBREAST CANCER Baylor Breast Care Center 15
Testing effectiveness (Phase 2)Ended earlyNCT03519178What this trial is testingPF-06873600 in People With CancerWho this might be right forHR+ HER2- Metastatic Breast Cancer, Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer, Triple Negative Breast Cancer, Male Breast Cancer Pfizer 155
Large-scale testing (Phase 3)Study completedNCT00291759What this trial is testingABCSG 8 - Adjuvant Treatment in Patients With Hormone Receptor-positive Breast Cancer With Good to Moderate Differentiation.Who this might be right forBreast Cancer AstraZeneca 3,858
Testing effectiveness (Phase 2)Ended earlyNCT03330405What this trial is testingJavelin Parp Medley: Avelumab Plus Talazoparib In Locally Advanced Or Metastatic Solid TumorsWho this might be right forAvelumab in Combination With Talazoparib Will be Investigated in Patients With Locally Advanced (Primary or Recurrent) or Metastatic Solid Tumors Pfizer 223
Large-scale testing (Phase 3)Study completedNCT03969121What this trial is testingNeoadjuvant Hormonal Therapy Plus Palbociclib in Operable, Hormone Sensitive and HER2-Negative Primary Breast CancerWho this might be right forBreast Cancer FemaleHormone Receptor Positive Malignant Neoplasm of Breast Kyoto Breast Cancer Research Network 141
Testing effectiveness (Phase 2)UnknownNCT00931450What this trial is testingSunitinib Malate and Exemestane in Treating Postmenopausal Women With Breast CancerWho this might be right forBreast Cancer Institut Català d'Oncologia 70